ZERIA PHARMACEUTICAL CO., LTD.
ゼリア新薬工業株式会社
Ticker: 4559 · Updated Jun 25, 2026 10:00
Last Updated
Jun 25, 2026 10:00
Period:
Display Units:
Figures:
¥ millions · Annual
Tip: select a row to chart its trend.
Income Statement
Income Statement J-GAAP Consolidated | FY2016 Mar 31, 2017 | FY2017 Mar 31, 2018 | FY2018 Mar 31, 2019 | FY2019 Mar 31, 2020 | FY2020 Mar 31, 2021 Restated later | FY2021 Mar 31, 2022 | FY2022 Mar 31, 2023 | FY2023 Mar 31, 2024 | FY2024 Mar 31, 2025 | FY2025 Mar 31, 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| 64,850 | 64,569 | 61,832 | 60,427 | 55,442 (Restated in the FY2021 report: 52,757) | 59,533 | 68,383 | 75,725 | 87,311 | 89,159 | |
YoY Change | Not available | -0.4% | -4.2% | -2.3% | -8.2% | 12.8% | 14.9% | 10.7% | 15.3% | 2.1% |
| 18,169 | 18,342 | 17,753 | 16,644 | 15,797 (Restated in the FY2021 report: 15,796) | 17,385 | 18,895 | 20,224 | 23,351 | 23,977 | |
| 46,681 | 46,227 | 44,079 | 43,783 | 39,645 (Restated in the FY2021 report: 36,961) | 42,148 | 49,489 | 55,501 | 63,960 | 65,183 | |
YoY Change | Not available | -1.0% | -4.6% | -0.7% | -9.5% | 14.0% | 17.4% | 12.1% | 15.2% | 1.9% |
| 42,150 | 41,405 | 40,334 | 39,697 | 36,193 (Restated in the FY2021 report: 33,485) | 35,782 | 40,474 | 45,880 | 51,762 | 52,808 | |
| 4,542 | 4,830 | 3,737 | 4,095 | 3,442 (Restated in the FY2021 report: 3,476) | 6,366 | 9,015 | 9,622 | 12,198 | 12,374 | |
YoY Change | Not available | 6.4% | -22.6% | 9.6% | -15.9% | 83.2% | 41.6% | 6.7% | 26.8% | 1.4% |
| 337 | 490 | 291 | 310 | 373 | 288 | 379 | 653 | 1,503 | 780 | |
| 441 | 231 | 732 | 526 | 640 | 718 | 1,815 | 1,761 | 860 | 2,111 | |
| 4,438 | 5,089 | 3,296 | 3,879 | 3,175 (Restated in the FY2021 report: 3,209) | 5,936 | 7,579 | 8,513 | 12,841 | 11,043 | |
| 810 | 691 | 1,985 | 45 | 1,059 | 18 | 22 | 1,479 | 3 | 169 | |
| 327.9 | 203.0 | 59.5 | 3.7 | 310.9 | 232.0 | 328.6 | 483.7 | 225.1 | 12.0 | |
| 4,921 | 5,577 | 5,221 | 3,920 | 3,923 (Restated in the FY2021 report: 3,957) | 5,722 | 7,273 | 9,508 | 12,619 | 11,200 | |
| 1,345 | 1,394 | 1,757 | 981 | 791 (Restated in the FY2021 report: 802) | 1,747 | 1,066 | 1,813 | 2,651 | 2,783 | |
| 3,576 | 4,183 | 3,464 | 2,939 | 3,131 (Restated in the FY2021 report: 3,155) | 3,975 | 6,207 | 7,695 | 9,968 | 8,417 | |
| -1,890 | 5,328 | -3,113 | -4,410 | 3,095 | -982 | 6,651 | 8,395 | 1,984 | 12,510 | |
| 1,686 | 9,511 | 350 | -1,471 | 6,227 (Restated in the FY2021 report: 6,250) | 2,993 | 12,858 | 16,090 | 11,952 | 20,927 |
Notes
- Figures in ¥ millions
- Financial data sourced from official Japanese regulatory disclosures
- Each column header links to its source filing; select a line to see its XBRL elements.
- Each year is shown as filed in that year's own report. Switch to Restated to see a year as the next year's report restated it; restated cells are marked R.
- Displaying 10 of 10 periods
- YoY Change compares each period with the same period a year earlier. A full year's change uses the prior year as that year's own report restates it (cells marked R), so it can differ from the change between the two columns as filed.
- FY = fiscal year, named by the calendar year it starts in; the month in brackets is when it ends (FY2025 ends Mar 2026 for a March year-end). FY2025 (Mar 2026) runs Apr 1, 2025 – Mar 31, 2026.
Get this data via the API
curl https://hachiquant.com/api/v1/companies/4559/income-statements?view=canonical curl https://hachiquant.com/api/v1/companies/4559/metrics No key needed. API reference